A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
Clinical trial NCT00006211 · COMPLETED
Trial details
- NCT number
- NCT00006211
- Sponsor
- Agouron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.